Your browser doesn't support javascript.
loading
Prevalence evolution of SARS-CoV-2 infection in the Municipality of Sao Paulo, 2020 - 2021
Jose Olimpio Moura de Albuquerque; Gabriela Akemi Kamioka; Geraldine Madalosso; Selma Anequini Costa; Paula Bisordi Ferreira; Francisco Alberto Pino; Ana Paula Sayuri Sato; Ana Carolina Aguiar de Carvalho; Ana Beatriz Pagliaro Amorim; Caroline Cotrim Aires; Ana Paula Arruda Geraldes Kataoka; Elisa San Martin Mouriz Savani; Thirsa Alvares Franco Bessa; Breno Souza de Aguiar; Marcelo Antunes Failla; Edson Aparecido dos Santos; Edjane Maria Torreao Brito; Maria Cristina Honorio dos Santos; Solange Maria Saboia e Silva; Luiz Artur Vieira Caldeira; Luiz Carlos Zamarco; Sandra Maria Sabino Fonseca; Marcia Maria de Cerqueira Lima; Ivanilda Argenau Marques; Fabiana Erica Vilanova da Silva; Paula Regina Glasser; Patricia Carla Piragibe Ramos Burihan; Cinthya Luzia Cavazzana; Renata Campos Lara; Debora Silva de Mello; Alessandra Cristina Guedes Pellini; Fernando Yoshiki Nishio; Fernanda Miyashiro Kian; Elza de Santana Braga; Nilza Maria Piassi Bertelli; Wagner Fracini; Marcelo Dell Aquila Goncalves; Paulete Secco Zular; Regiane de Santana Piva; Eduardo de Masi.
Affiliation
  • Jose Olimpio Moura de Albuquerque; Secretaria Municipal da Saude de Sao Paulo/COVISA
  • Gabriela Akemi Kamioka; Secretaria Municipal da Saude de Sao Paulo/COVISA. Faculdade de Saude Publica da USP.
  • Geraldine Madalosso; Secretaria Municipal da Saude de Sao Paulo/COVISA
  • Selma Anequini Costa; Secretaria Municipal de Saude de Sao Paulo/COVISA
  • Paula Bisordi Ferreira; Secretaria Municipal da Saude de Sao Paulo/COVISA
  • Francisco Alberto Pino; Secretaria de Agricultura e Abastecimento do Estado de Sao Paulo/IEA
  • Ana Paula Sayuri Sato; Faculdade de Saude Publica USP
  • Ana Carolina Aguiar de Carvalho; Secretaria Municipal da Saude de Sao Paulo/COVISA
  • Ana Beatriz Pagliaro Amorim; Secretaria Municipal da Saude de Sao Paulo/COVISA
  • Caroline Cotrim Aires; Secretaria Municipal da Saude de Sao Paulo/COVISA
  • Ana Paula Arruda Geraldes Kataoka; Secretaria Municipal da Saude de Sao Paulo/COVISA
  • Elisa San Martin Mouriz Savani; Secretaria Municipal da Saude de Sao Paulo/COVISA
  • Thirsa Alvares Franco Bessa; Secretaria Municipal da Saude de Sao Paulo/CCZ
  • Breno Souza de Aguiar; Secretaria Municipal da Saude de Sao Paulo/CEINFO
  • Marcelo Antunes Failla; Secretaria Municipal da Saude de Sao Paulo/CEINFO
  • Edson Aparecido dos Santos; Secretaria Municipal da Saude de Sao Paulo
  • Edjane Maria Torreao Brito; Secretaria Municipal da Saude de Sao Paulo
  • Maria Cristina Honorio dos Santos; Secretaria Municipal da Saude da Sao Paulo
  • Solange Maria Saboia e Silva; Secretaria Municipal da Saude de Sao Paulo/COVISA
  • Luiz Artur Vieira Caldeira; Secretaria Municipal da Saude de Sao Paulo/COVISA
  • Luiz Carlos Zamarco; Secretaria Municipal da Saude de Sao Paulo
  • Sandra Maria Sabino Fonseca; Secretaria Municipal da Saude de Sao Paulo
  • Marcia Maria de Cerqueira Lima; Secretaria Municipal da Saude de Sao Paulo
  • Ivanilda Argenau Marques; Secretaria Municipal da Saude de Sao Paulo
  • Fabiana Erica Vilanova da Silva; Secretaria Municipal da Saude de Sao Paulo
  • Paula Regina Glasser; Secretaria Municipal da Saude de Sao Paulo/COVISA
  • Patricia Carla Piragibe Ramos Burihan; Secretaria Municipal da Saude de Sao Paulo/COVISA
  • Cinthya Luzia Cavazzana; Secretaria Municipal da Saude de Sao Paulo/COVISA
  • Renata Campos Lara; Secretaria Municipal da Saude de Sao Paulo/COVISA
  • Debora Silva de Mello; Secretaria Municipal da Saude de Sao Paulo/COVISA
  • Alessandra Cristina Guedes Pellini; Universidade Nove de Julho. Secretaria Municipal da Saude de Sao Paulo/CEINFO
  • Fernando Yoshiki Nishio; Secretaria Municipal da Saude de Sao Paulo/COVISA
  • Fernanda Miyashiro Kian; Secretaria Municipal da Saude de Sao Paulo/COVISA
  • Elza de Santana Braga; Secretaria Municipal da Saude de Sao Paulo/CRS Leste
  • Nilza Maria Piassi Bertelli; Secretaria Municipal da Saude de Sao Paulo/CRS Sudeste
  • Wagner Fracini; Secretaria Municipal da Saude de Sao Paulo/CRS Norte
  • Marcelo Dell Aquila Goncalves; Secretaria Municipal da Saude de Sao Paulo/CRS Sul
  • Paulete Secco Zular; Secretaria Municipal da Saude de Sao Paulo/CRS Centro
  • Regiane de Santana Piva; Secretaria Municipal de Saude de Sao Paulo/CRS Oeste
  • Eduardo de Masi; Secretaria Municipal da Saude de Sao Paulo/COVISA
Preprint in English | medRxiv | ID: ppmedrxiv-21256530
ABSTRACT
ObjectivesTo estimate the evolution of the prevalence of SARS-CoV-2 virus infection among residents aged 18 years or over in the municipality of Sao Paulo. MethodsThis is a population-based household survey conducted every 15 days, between June and September 2020 and January and February 2021. In total, 11 phases were performed. The presence of antibodies against SARS-CoV-2 was identified in venous blood using a lateral flow test, Wondfo Biotech. In the last phase, it was combined with an immunoenzymatic test, Euroimmun. Participants also answered a semi-structured questionnaire on sociodemographic and economic factors and social distancing measures. Prevalence estimates and 95% confidence intervals were estimated according to the region, Human Development Index, sex, age group, ethnicity, education, income and variables associated with risk or prevention of the infection. To compare the frequencies among the categories of each variable, the chi-square test with Rao Scott correction was used, considering a 5% significance level. ResultsIn total, 23,397 individuals were interviewed and had their samples collected. The estimated prevalence of antibodies against SARS-CoV-2 ranged from 9.7% (95%CI 7.9-11.8%) to 25.0% (95%CI 21.7-28.7). The prevalence of individuals with antibodies against SARS-CoV-2 was higher among black and pardo people, people with lower schooling, people with lower income and among residents of regions with lower Human Development Index. The lowest prevalences were associated with recommended measures of disease protection. The proportion of asymptomatic infection was 45.1%. ConclusionThe estimated prevalence of SARS-CoV-2 infection was lower than the cumulative incidence variation, except for the last phase of the study. The differences in prevalence estimates observed among subpopulations showed the social inequality as a risk of infection. The lower prevalence observed among those who could follow prevention measures reinforce the need to maintain the social distancing measures as ways to prevent SARS-CoV-2 infection.
License
cc_by_nc_nd
Full text: Available Collection: Preprints Database: medRxiv Type of study: Observational study / Prognostic study / Qualitative research Language: English Year: 2021 Document type: Preprint
Full text: Available Collection: Preprints Database: medRxiv Type of study: Observational study / Prognostic study / Qualitative research Language: English Year: 2021 Document type: Preprint
...